Navigation Links
OXiGENE Abstracts Published in ASCO Program

eve synergistic antitumor activity when administered concurrently. In animal studies, ZYBRESTAT has been shown to enhance the anti-tumor effects of several chemotherapeutic agents, several anti-angiogenic drugs, and radiation.

OXi4503 is a novel, second-generation vascular disrupting agent with potential intrinsic cytotoxicity exerted through an ortho-quinone metabolite. The drug candidate has demonstrated single-agent activity in human tumor xenograft models. Preclinical research with OXi4503 suggests that it not only shuts down tumor blood flow, but can also be metabolized into a compound which could assist with killing the remaining tumor cells at the periphery of the tumor by direct cytotoxic activity against tumor cells. In December 2004, the United Kingdom regulatory authorities accepted an application from our collaborators, Cancer Research UK, to initiate a dose-escalating Phase I clinical trial of OXi4503 in patients with advanced cancer. This trial is currently ongoing. In 2007, OXiGENE plans to initiate several preclinical studies to evaluate OXi4503 and possibly a Phase Ib clinical trial of OXi4503 in combination with an approved anti-angiogenic therapeutic.

About OXiGENE, Inc.

OXiGENE is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases. The Company's major focus is the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property position and therapeutic development expertise to bring life saving and enhancing medicines to patients.

Safe Harbor Statement

This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any or all of the forward-looking statements in this press release including the initiation of further clinical trials with
'"/>




Page: 1 2 3 4

Related medicine technology :

1. OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology
2. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
3. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
4. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
5. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
6. SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
9. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
10. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
11. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: OXiGENE Abstracts Published ASCO Program
(Date:4/17/2015)... SINGAPORE , April 17, 2015 ... a leading Life Science and High Technology company, ... Asia Pacific headquarters and state-of-the-art Cell ... Research Park, the facility will provide customized support ... leading scientific capabilities. "Our new Technical ...
(Date:4/16/2015)... April 16, 2015 Vanda Pharmaceuticals Inc. (Vanda) ... the development and commercialization of products for the treatment ... release results for the first quarter of 2015 on ... The Company will host a conference call ... during which Vanda management will discuss the first quarter ...
(Date:4/16/2015)... BEDFORD, Mass. , April 16, 2015 /PRNewswire/ ... an important cervical cancer screening study i ... , a peer-reviewed journal of the American Cancer ... Quest Diagnostics and the University of Pittsburgh Medical Center, supports ... screening, which recommend that women 30-65 years of ...
Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
... , ATLANTA , Feb. 1 ... that provides healthcare professionals, patients, investors and the public with ... solutions for treating cancer and brain disorders. , Designed ... functionality, including a new, clean design that appeals to a ...
... NANTONG, China , ... "Company") (OTC Bulletin Board: SNBP) is pleased to,announce that ... (Cisatracurium Besylate), for coverage under National Basic,Medical Insurance, Employment ... KuTai (Cisatracurium Besylate), on the market since ...
Cached Medicine Technology:Elekta Launches New Web Site for Global Health Care Community 2Elekta Launches New Web Site for Global Health Care Community 3China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 2China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 3
(Date:4/17/2015)... (PRWEB) April 17, 2015 In Defense ... the following statement: “On Wednesday April 15th, the European ... adopted a resolution recognizing the Armenian Genocide, “paying tribute, ... of the one-and-a-half million innocent Armenian victims who perished ... (IDC) extols the EU for this timely and needed ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 As a ... in his new offering of platelet-rich plasma (PRP) ... Medicine (MOSM) is known for its world-class care ... brings extensive surgical experience lacking in many other physicians ... cell treatments are utilized for pain management and rehabilitation. ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
(Date:4/17/2015)... Connie Casad, M.D., a well-known and respected gynecologist, ... years of practice experience in Dallas, Texas, has announced ... for her patients with the availability of a reader’s ... with a brief synopsis on each for her patients. ... providing this service, Dr. Casad said, “Furnishing a researched ...
(Date:4/17/2015)... Jersey City, NJ (PRWEB) April 17, 2015 ... is stored in the posterior pituitary and thought to ... strengthening bonding between couples. To further substantiate this, new ... published in the journal, Nature, and reported by Medical ... does have a powerful influence over maternal social behavior. ...
Breaking Medicine News(10 mins):Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3
... head of the World Health Organization (WHO), Dr Anders Nordstrom, ... // , confirmed that Dr Anders Nordstrom. He also emphasized ... the people to continue the fight against HIV/Aids, malaria and ... work of his predecessor Dr Lee Jong-wook, who had passed ...
... detect AIDS. It is waiting for the FDA to give ... The Nasdaq-listed company already sells the kit to hospitals and ... this product would become an important weapon to fight against ... diagnosis was made. Statistics show that more than one million ...
... Scotland (HPS) said that a new strain of E. coli ... had been seen in Europe and Australia, but is apparently ... reacts differently in the laboratory from other types of E.coli ... out more about it,' said HPS consultant Dr John Cowden. ...
... Canada's health ministry asked patients suffering from high blood ... ailments such as hardening of the arteries // , ... Disorder (ADHD) drugs. This is because there is an ... rare heart-related side effects. Health Canada also asked the ...
... breastfed their babies in public are put under jail for ... that breastfeeding was an adverse thing, clinicians proved it is ... Healthy People 2010 target is to increase the proportion of ... six months to 50%; the World Health Organization recommends that ...
... have warned that the growing menace of potentially lethal ... there would be a global health crisis. ... the developed and developing world," said Jo Harkness, of ... penalties for counterfeits are shocking. Countering supply chains is ...
Cached Medicine News:Health News:Breastfeeding Mothers Arrested For Public Indecency 2
... a low-profile, wraparound, hinged knee product with ... patients who have difficulty applying a sleeve, ... for ease of application. These pull ... easily secure the anterior closure of the ...
... might just be the world's most versatile ... support, post-op/rehab support, or both, Flex is ... Accutrac™ ROM hinges control flexion and extension ... durability while being heat-moldable to accommodate changes ...
... CartiCare enables unloading of the medial or ... with unicompartmental osteoarthritis. Plus, we equipped this ... hinge, making it further suitable for post-op ... and/or adjustable flexion/extension control. , ,Indications: ...
... of the Custom Montana2 alleviates the ... three-point load across the knee joint, ... area. The Diagonal Loading Strap gives ... the load to accommodate their daily ...
Medicine Products: